Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Squamous cell lung cancer: Current landscape and future therapeutic options
Sally C. M. Lau, Yuanwang Pan, Vamsidhar Velcheti, et al.
Cancer Cell (2022) Vol. 40, Iss. 11, pp. 1279-1293
Open Access | Times Cited: 91

Showing 1-25 of 91 citing articles:

Heterogeneity and plasticity of epithelial–mesenchymal transition (EMT) in cancer metastasis: Focusing on partial EMT and regulatory mechanisms
Dandan Li, Lingyun Xia, Pan Huang, et al.
Cell Proliferation (2023) Vol. 56, Iss. 6
Open Access | Times Cited: 77
KMT2D deficiency drives lung squamous cell carcinoma and hypersensitivity to RTK-RAS inhibition
Yuanwang Pan, Han Han, Hai Hu, et al.
Cancer Cell (2022) Vol. 41, Iss. 1, pp. 88-105.e8
Open Access | Times Cited: 45
Immunotherapy for advanced-stage squamous cell lung cancer: the state of the art and outstanding questions
Yibei Wang, Mohammed Safi, Fred R. Hirsch, et al.
Nature Reviews Clinical Oncology (2025) Vol. 22, Iss. 3, pp. 200-214
Closed Access | Times Cited: 1
Metabolomic differentiation of benign vs malignant pulmonary nodules with high specificity via high-resolution mass spectrometry analysis of patient sera
Yao Yao, Xueping Wang, Jian Guan, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 18
Smoking-induced CCNA2 expression promotes lung adenocarcinoma tumorigenesis by boosting AT2/AT2-like cell differentiation
Qiangqiang He, Meiyu Qu, Chengyun Xu, et al.
Cancer Letters (2024) Vol. 592, pp. 216922-216922
Closed Access | Times Cited: 5
Reactive oxygen species control protein degradation at the mitochondrial import gate
Rachael McMinimy, Andrew G. Manford, Christine L. Gee, et al.
Molecular Cell (2024) Vol. 84, Iss. 23, pp. 4612-4628.e13
Closed Access | Times Cited: 5
Role of COL5A1 in lung squamous cell Carcinoma: Prognostic Implications and therapeutic potential
Chengjuan Zhang, Bo Wang, Tingjie Wang, et al.
International Immunopharmacology (2025) Vol. 147, pp. 113977-113977
Closed Access
Comparative Analysis of Transcriptomic and Proteomic Expression between Two Non-Small Cell Lung Cancer Subtypes
Ben Nicholas, A.G. Bailey, Katy J. McCann, et al.
Journal of Proteome Research (2025) Vol. 24, Iss. 2, pp. 729-741
Open Access
Efficacy and Safety of Ivonescimab in the Treatment of Advanced Non-small Cell Lung Cancer (NSCLC): A Systematic Review
Alzahra'a Al matairi, Bara M. Hammadeh, Abdullah Yousef Aldalati, et al.
Cureus (2025)
Open Access
A panel of cancer testis antigens in squamous cell carcinoma of the lung, head and neck, and esophagus: implication for biomarkers and therapeutic targets
Lin Li, Xin Zhang, Jiayao Yan, et al.
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access
Squamous cell cancers of the aero-upper digestive tract: A unified perspective on biology, genetics, and therapy
Brian S. Henick, Alison Taylor, Hiroshi Nakagawa, et al.
Cancer Cell (2025) Vol. 43, Iss. 2, pp. 178-194
Closed Access
Targeting novel regulated cell death: disulfidptosis in cancer immunotherapy with immune checkpoint inhibitors
Fei Du, Guojun Wang, Qian Dai, et al.
Biomarker Research (2025) Vol. 13, Iss. 1
Open Access
The critical role of immune response in lung cancer and its treatment progress
Ying Zhang
New discovery. (2025), pp. 1-12
Closed Access
HDCA6 suppresses GATA6 expression to enhance cellular growth and migration in lung squamous cell carcinoma
Changhua Huang, Hua Yang, Hailong Wang, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2025) Vol. 1871, Iss. 5, pp. 167757-167757
Closed Access
The Role of Yes‐Associated Protein in Inflammatory Diseases and Cancer
Bing Zhong, Jintao Du, Feng Liu, et al.
MedComm (2025) Vol. 6, Iss. 3
Open Access
Diagnostic and Prognostic Value of hsa_piR_022710, hsa_piR_019822, and hsa_piR_020840 in Early-Stage Non-Small-Cell Lung Cancer: Implications for Recurrence and Survival in Squamous Cell Carcinoma Patients
Yangyi He, Antonio Altuna-Coy, Melissa Acosta-Plasencia, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 7, pp. 2870-2870
Open Access
Elevated expression of ANAPC1 in lung squamous cell carcinoma: clinical implications and mechanisms
Xiaosong Chen, Feng Chen, Shu-Jia He, et al.
Future Science OA (2025) Vol. 11, Iss. 1
Open Access
Metabolomic machine learning-based model predicts efficacy of chemoimmunotherapy for advanced lung squamous cell carcinoma
Liang Zheng, Wei Nie, Shuyuan Wang, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Clinicopathologic features of histologic transformation in lung adenocarcinoma after treatment with epidermal growth factor receptor-tyrosine kinase inhibitors
Halim Song, Deokhoon Kim, Se Jin Jang, et al.
Annals of Diagnostic Pathology (2025), pp. 152478-152478
Closed Access
Molecular signatures bidirectionally link myocardial infarction and lung cancer
Dhruva Nandi, Rajiv Janardhanan, Sridhar Hannenhalli, et al.
Frontiers in Medicine (2025) Vol. 12
Open Access
Function of antigen-presenting cells in non-small-cell lung cancer (NSCLC)
Rakesh Kumar, Kamal Jain, Shashi Raj K, et al.
Medical Oncology (2025) Vol. 42, Iss. 5
Closed Access
Predictive Performance of Postoperative Recurrence in Lung Squamous Cell Carcinoma Using Machine Learning Based on Nuclear Morphological Features
Tomokazu Omori, Akira Saitō, Yoshihisa Shimada, et al.
(2025)
Closed Access
Identification of potential diagnostic targets and therapeutic strategies for anoikis-related biomarkers in lung squamous cell carcinoma using machine learning and computational virtual screening
Xin Zhang, Jing Zou, Jinghua Ning, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
AKAP12, mediated by transcription factor 21, inhibits cell proliferation, metastasis, and glycolysis in lung squamous cell carcinoma
Xinguang Chen, Hehe Liao, K. Wang, et al.
Open Life Sciences (2025) Vol. 20, Iss. 1
Open Access
Construction of a prognostic model with CAFs for predicting the prognosis and immunotherapeutic response of lung squamous cell carcinoma
Xiang Zhang, Qingqing Xiao, Cong Zhang, et al.
Journal of Cellular and Molecular Medicine (2024) Vol. 28, Iss. 8
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top